Kunal Singh

Kunal Singh

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KVKavita Vats
Kavita Vats
HTHua Tian
Hua Tian
KSKunal Singh
Kunal Singh
YTYulia Y. Tyurina
Yulia Y. Tyurina
LSLouis J. Sparvero
Louis J. Sparvero
YBYuri Bunimovich
Yuri Bunimovich
Dysregulations of epithelial-immune interactions frequently culminate in chronic inflammatory diseases of the skin, lungs, kidneys, and gastrointestinal tract. Yet, the intraepithelial processes that initiate and perpetuate inflammation in these organs are poorly understood. Here, by utilizing redox lipidomics we identified ferroptosis-associated peroxidation of polyunsaturated phosphatidylethanolamines in the epithelia of patients with asthma, cystic fibrosis, psoriasis, and renal failure. Focusing on psoriasis as a disease model, we used high-resolution mass spectrometry imaging and identified keratin 14–expressing (K14-expressing) keratinocytes executing a ferroptotic death program in human psoriatic skin. Psoriatic phenotype with characteristic Th1/Th17 skin and extracutaneous immune responses was initiated and maintained in a murine model designed to actuate ferroptosis in a fraction of K14 + glutathione peroxidase 4–deficient (Gpx4-deficient) epidermal keratinocytes. Importantly, an antiferroptotic agent, liproxstatin-1, was as effective as clinically relevant biological IL-12/IL-23/TNF-α–targeting therapies or the depletion of T cells in completely abrogating molecular, biochemical, and morphological features of psoriasis. As ferroptosis in select epidermal keratinocytes triggers and sustains a pathological psoriatic multiorgan inflammatory circuit, we suggest that strategies targeting ferroptosis or its causes may be effective in preventing or ameliorating a variety of chronic inflammatory diseases.

22 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AVAbhishek Vats
Abhishek Vats
KVKavita Vats
Kavita Vats
KSKunal Singh
Kunal Singh
ASAman Shah
Aman Shah
CQCheng Qian
Cheng Qian
DZDonald J. Zack
Donald J. Zack
Inducible CreERT-mediated gene editing is a powerful tool for targeted gene manipulation, but systemic tamoxifen (Tam) administration can cause off-target effects and toxicity. Here we demonstrate that topical administration of 4-hydroxytamoxifen (4-OHT) eye drops in Plp1-CreERT/tdTomatof/f mice effectively induces CreERT-mediated recombination specifically in oligodendrocytes of the optic nerve, optic chiasm, and adjacent CNS regions including the optic tract, hippocampus, and corpus callosum. This localized approach achieves robust tdTomato expression in over 80% of oligodendrocytes without detectable retinal structural or functional abnormalities, as confirmed by electroretinography and fundus imaging. These findings demonstrate a safe, non-invasive method for spatially restricted gene editing in the visual pathway and certain brain areas, providing a valuable platform for investigating oligodendrocyte biology and demyelinating diseases while minimizing systemic side effects associated with Tam treatment.